Synergistic Action of Immunotherapy and Nanotherapy against Cancer Patients Infected with SARS-CoV-2 and the Use of Artificial Intelligence.

Gupta, Tanvi; Debele, Tilahun Ayane; Wei, Yu-Feng; Gupta, Anish; Murtaza, Mohd; Su, Wen-Pin

Gupta, Tanvi; Debele, Tilahun Ayane; Wei, Yu-Feng; Gupta, Anish; Murtaza, Mohd; Su, Wen-Pin.

Afiliación

Gupta T; Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan 704, Taiwan.
Debele TA; Department of Biomedical, Chemical & Environmental Engineering, College of Engineering and Applied Science (CEAS), University of Cincinnati, Cincinnati, OH 45221, USA.
Wei YF; Department of Internal Medicine, School of Medicine for International Students, College of Medicine, E-Da Cancer Hospital, I-Shou University, Kaohsiung 824, Taiwan.
Gupta A; Devscope IT, First Floor, 40A/B Gandhi Nagar, Jammu 180001, India.
Murtaza M; Microbial Biotechnology Division, CSIR-Indian Institute of Integrative Medicine, Jammu 180012, India.
Su WP; Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan 704, Taiwan.

Cancers (Basel) ; 14(1)2022 Jan 02.

Article en En | MEDLINE | ID: mdl-35008377

Palabras clave

artificial intelligence; cancer; immunotherapy; nanotherapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancers (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Taiwán Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google